Paul C Makhlouf, MD - Medicare Nuclear Medicine in Naples, FL

Paul C Makhlouf, MD is a medicare enrolled "Nuclear Medicine" physician in Naples, Florida. He graduated from medical school in 2002 and has 22 years of diverse experience with area of expertise as Nuclear Medicine. He is a member of the group practice Florida Cancer Specialists And Research Institute, Llc and his current practice location is 5856 Whisperwood Ct, Naples, Florida. You can reach out to his office (for appointments etc.) via phone at (804) 514-7627.

Paul C Makhlouf is licensed to practice in Florida (license number ME98397) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1457553398.

Contact Information

Paul C Makhlouf, MD
5856 Whisperwood Ct,
Naples, FL 34110-2307
(804) 514-7627
Not Available



Physician's Profile

Full NamePaul C Makhlouf
GenderMale
SpecialityNuclear Medicine
Experience22 Years
Location5856 Whisperwood Ct, Naples, Florida
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Paul C Makhlouf graduated from medical school in 2002
  NPI Data:
  • NPI Number: 1457553398
  • Provider Enumeration Date: 06/04/2007
  • Last Update Date: 03/02/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 6103915624
  • Enrollment ID: I20071207000323

Medical Identifiers

Medical identifiers for Paul C Makhlouf such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1457553398NPI-NPPES
ME98397OtherFLMEDICAL LICENSE
279965100MedicaidFL
02631OtherFLBCBS OF FL

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2085N0904XRadiology - Nuclear Radiology ME98397 (Florida)Secondary
207U00000XNuclear Medicine ME98397 (Florida)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Florida Cancer Specialists And Research Institute, Llc2567356058382

News Archive

Study shows long-term benefit of preventative artery repair after serious heart attack

A major international study has shown that opening all clogged arteries with stents after a serious heart attack is much better than opening only the single clogged artery that caused the heart attack.

HCA Healthcare UK introduces ground-breaking new blood cancer treatment

HCA Healthcare UK has announced the launch of CAR T-cell therapy - a ground-breaking new blood cancer treatment which will be available to eligible patients with Diffuse Large B-Cell Lymphoma and Acute Lymphoblastic Leukaemia.

Scientists at Sheffield Hallam University receive major funding boost for animal-testing reduction project

Almost a quarter of a million pounds has been awarded to a team of scientists at Sheffield Hallam University to develop a new technique that will reduce the need for animal testing in pre-clinical research projects.

Viewpoints: 'Accepted wisdom' about cutting entitlements disputed; Profit motive doesn't lead to good health care

It has become accepted economic wisdom that the only way to get control over America's looming budget deficits is to "reform entitlements." The accepted wisdom is wrong. ... Medicare and Medicaid costs are projected to soar. But here again, look closely and you'll see neither is really the problem. The underlying problem is the soaring cost of health care overall, combined with the aging of the boomer generation.

New technology predicts effectiveness of chemotherapy after one treatment

While early detection of breast cancer is critical, early prediction of how well the neoadjuvant chemotherapy treatment before surgery is working also may provide a window of opportunity when treatment could be altered and have a big impact on the patient's quality of life.

Read more Medical News

› Verified 7 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Paul C Makhlouf allows following entities to bill medicare on his behalf.
Entity NameFlorida Cancer Specialists & Research Institute, Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1760590962
PECOS PAC ID: 2567356058
Enrollment ID: O20040216000091

News Archive

Study shows long-term benefit of preventative artery repair after serious heart attack

A major international study has shown that opening all clogged arteries with stents after a serious heart attack is much better than opening only the single clogged artery that caused the heart attack.

HCA Healthcare UK introduces ground-breaking new blood cancer treatment

HCA Healthcare UK has announced the launch of CAR T-cell therapy - a ground-breaking new blood cancer treatment which will be available to eligible patients with Diffuse Large B-Cell Lymphoma and Acute Lymphoblastic Leukaemia.

Scientists at Sheffield Hallam University receive major funding boost for animal-testing reduction project

Almost a quarter of a million pounds has been awarded to a team of scientists at Sheffield Hallam University to develop a new technique that will reduce the need for animal testing in pre-clinical research projects.

Viewpoints: 'Accepted wisdom' about cutting entitlements disputed; Profit motive doesn't lead to good health care

It has become accepted economic wisdom that the only way to get control over America's looming budget deficits is to "reform entitlements." The accepted wisdom is wrong. ... Medicare and Medicaid costs are projected to soar. But here again, look closely and you'll see neither is really the problem. The underlying problem is the soaring cost of health care overall, combined with the aging of the boomer generation.

New technology predicts effectiveness of chemotherapy after one treatment

While early detection of breast cancer is critical, early prediction of how well the neoadjuvant chemotherapy treatment before surgery is working also may provide a window of opportunity when treatment could be altered and have a big impact on the patient's quality of life.

Read more Medical News

› Verified 7 days ago

Entity NameRrc Vascular Specialists Inc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1871778894
PECOS PAC ID: 8820177611
Enrollment ID: O20080505000770

News Archive

Study shows long-term benefit of preventative artery repair after serious heart attack

A major international study has shown that opening all clogged arteries with stents after a serious heart attack is much better than opening only the single clogged artery that caused the heart attack.

HCA Healthcare UK introduces ground-breaking new blood cancer treatment

HCA Healthcare UK has announced the launch of CAR T-cell therapy - a ground-breaking new blood cancer treatment which will be available to eligible patients with Diffuse Large B-Cell Lymphoma and Acute Lymphoblastic Leukaemia.

Scientists at Sheffield Hallam University receive major funding boost for animal-testing reduction project

Almost a quarter of a million pounds has been awarded to a team of scientists at Sheffield Hallam University to develop a new technique that will reduce the need for animal testing in pre-clinical research projects.

Viewpoints: 'Accepted wisdom' about cutting entitlements disputed; Profit motive doesn't lead to good health care

It has become accepted economic wisdom that the only way to get control over America's looming budget deficits is to "reform entitlements." The accepted wisdom is wrong. ... Medicare and Medicaid costs are projected to soar. But here again, look closely and you'll see neither is really the problem. The underlying problem is the soaring cost of health care overall, combined with the aging of the boomer generation.

New technology predicts effectiveness of chemotherapy after one treatment

While early detection of breast cancer is critical, early prediction of how well the neoadjuvant chemotherapy treatment before surgery is working also may provide a window of opportunity when treatment could be altered and have a big impact on the patient's quality of life.

Read more Medical News

› Verified 7 days ago

Entity NameRadiology Regional Center Professional Services Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1619365772
PECOS PAC ID: 3274858295
Enrollment ID: O20150216001973

News Archive

Study shows long-term benefit of preventative artery repair after serious heart attack

A major international study has shown that opening all clogged arteries with stents after a serious heart attack is much better than opening only the single clogged artery that caused the heart attack.

HCA Healthcare UK introduces ground-breaking new blood cancer treatment

HCA Healthcare UK has announced the launch of CAR T-cell therapy - a ground-breaking new blood cancer treatment which will be available to eligible patients with Diffuse Large B-Cell Lymphoma and Acute Lymphoblastic Leukaemia.

Scientists at Sheffield Hallam University receive major funding boost for animal-testing reduction project

Almost a quarter of a million pounds has been awarded to a team of scientists at Sheffield Hallam University to develop a new technique that will reduce the need for animal testing in pre-clinical research projects.

Viewpoints: 'Accepted wisdom' about cutting entitlements disputed; Profit motive doesn't lead to good health care

It has become accepted economic wisdom that the only way to get control over America's looming budget deficits is to "reform entitlements." The accepted wisdom is wrong. ... Medicare and Medicaid costs are projected to soar. But here again, look closely and you'll see neither is really the problem. The underlying problem is the soaring cost of health care overall, combined with the aging of the boomer generation.

New technology predicts effectiveness of chemotherapy after one treatment

While early detection of breast cancer is critical, early prediction of how well the neoadjuvant chemotherapy treatment before surgery is working also may provide a window of opportunity when treatment could be altered and have a big impact on the patient's quality of life.

Read more Medical News

› Verified 7 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Paul C Makhlouf is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Paul C Makhlouf, MD
4371 Veronica S Shoemaker Blvd,
Fort Myers, FL 33916-2216

Ph: (239) 274-8200
Paul C Makhlouf, MD
5856 Whisperwood Ct,
Naples, FL 34110-2307

Ph: (804) 514-7627

News Archive

Study shows long-term benefit of preventative artery repair after serious heart attack

A major international study has shown that opening all clogged arteries with stents after a serious heart attack is much better than opening only the single clogged artery that caused the heart attack.

HCA Healthcare UK introduces ground-breaking new blood cancer treatment

HCA Healthcare UK has announced the launch of CAR T-cell therapy - a ground-breaking new blood cancer treatment which will be available to eligible patients with Diffuse Large B-Cell Lymphoma and Acute Lymphoblastic Leukaemia.

Scientists at Sheffield Hallam University receive major funding boost for animal-testing reduction project

Almost a quarter of a million pounds has been awarded to a team of scientists at Sheffield Hallam University to develop a new technique that will reduce the need for animal testing in pre-clinical research projects.

Viewpoints: 'Accepted wisdom' about cutting entitlements disputed; Profit motive doesn't lead to good health care

It has become accepted economic wisdom that the only way to get control over America's looming budget deficits is to "reform entitlements." The accepted wisdom is wrong. ... Medicare and Medicaid costs are projected to soar. But here again, look closely and you'll see neither is really the problem. The underlying problem is the soaring cost of health care overall, combined with the aging of the boomer generation.

New technology predicts effectiveness of chemotherapy after one treatment

While early detection of breast cancer is critical, early prediction of how well the neoadjuvant chemotherapy treatment before surgery is working also may provide a window of opportunity when treatment could be altered and have a big impact on the patient's quality of life.

Read more News

› Verified 7 days ago



Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.